Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions

Over 70-year-old Patients with Psoriasis

Interventions

BIOLOGICAL

Ixekizumab

injected with ixekizumab

BIOLOGICAL

Secukizumab

injected with secukizumab

All Listed Sponsors

collaborator

Zhejiang University

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06811558 - Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis | Biotech Hunter | Biotech Hunter